A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, RANDOMIZED, OBSERVER-BLIND, ACTIVE-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MRNA-1010 CANDIDATE SEASONAL INFLUENZA VACCINE IN ADULTS 50 YEARS AND OLDER

Intervention/treatment:
MRNA-1010 / FLUARIX QUADRIVALENT INFLUENZA VACCINE
Medical condition:
INFLUENZA
Protocol code:
MRNA-1010-P302
Control number:
267269
Status:
Closed
Approved:
October 12, 2022
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT05566639
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
50 Years and older
Accepts healthy volunteers: Yes

Contacts and locations

Contact
Name
Moderna Clinical Trials Support Center
Organization
ModernaTX, Inc.
Phone:
1-877-777-7187
Sponsor
MODERNATX, INC.

Locations

Aggarwal and Associates LTD
Brampton
Alpha Recherche Clinique Inc
Québec
Aviva Clinical Trials Group Inc
Burlington
Canadian Phase Onward Inc.
Toronto
Central Alberta Research Clinic
Red Deer
Centricity Research Quebec City
Lévis
Clinique de Lebourgneuf
Québec
Clinique spécialisée en allergie - Allergy/Immunology/Asthma/Mpoc
Québec
Colchester East Hants Health Authority - Colchester Regional
Truro
Diex Recherche - Joilette - HyperCore - PPDS
Saint-Charles-Borromée
Diex Recherche Trois-Rivières
Trois-Rivières
Diex Recherche Victoriaville
Victoriaville
DIEX Research Quebec Inc.
Québec, G1G 3Y8
DIEX Research Quebec Inc.
Québec, G1N 4V3
Diex Research Sherbrooke Inc
Québec
Glencar Medical Inc.
Sarnia
Hamilton Medical Research Group
Hamilton
LMC
Toronto
LMC Manna
Pointe-Claire
Manna Research
Toronto
Medicine Professional Corporation
Toronto
Milestone Research Inc.
London
Okanagan Clinical Trials
Kelowna
Toronto Western Hospital
Toronto
Yang Medicine
Ottawa

Results

See the results from the trial NCT05566639. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?